肝炎検査キット:医療機器パイプライン分析

◆英語タイトル:Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0213
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:279
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥420,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥840,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,260,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Hepatitis Test Kits – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Hepatitis Test Kits – Medical Devices Pipeline Assessment, 2019″ provides an overview of Hepatitis Test Kits currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Hepatitis Test Kits pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Hepatitis Test Kits under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Hepatitis Test Kits and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Hepatitis Test Kits under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 8
1.2 List of Figures 13
2 Introduction 14
2.1 Hepatitis Test Kits Overview 14
3 Products under Development 15
3.1 Hepatitis Test Kits – Pipeline Products by Stage of Development 15
3.2 Hepatitis Test Kits – Pipeline Products by Segment 16
3.3 Hepatitis Test Kits – Pipeline Products by Territory 17
3.4 Hepatitis Test Kits – Pipeline Products by Regulatory Path 18
3.5 Hepatitis Test Kits – Pipeline Products by Estimated Approval Date 19
4 Hepatitis Test Kits – Pipeline Products under Development by Companies 20
4.1 Hepatitis Test Kits Companies – Pipeline Products by Stage of Development 20
4.2 Hepatitis Test Kits – Pipeline Products by Stage of Development 22
5 Hepatitis Test Kits Companies and Product Overview 26
5.1 Abbott Diagnostics Company Overview 26
5.1.1 Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 26
5.2 Alderon Biosciences Inc Company Overview 29
5.2.1 Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 29
5.3 AutoGenomics Inc Company Overview 30
5.3.1 AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 AXO Science SAS Company Overview 32
5.4.1 AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 32
5.5 Beckman Coulter Inc Company Overview 33
5.5.1 Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 33
5.6 Biokit SA Company Overview 34
5.6.1 Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 34
5.7 Biomagnetics Diagnostics Corp Company Overview 37
5.7.1 Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 37
5.8 Bio-Rad Laboratories Inc Company Overview 38
5.8.1 Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 38
5.9 Boditech Med Inc Company Overview 39
5.9.1 Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 39
5.10 CeMines, Inc. (Inactive) Company Overview 42
5.10.1 CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 42
5.11 Cepheid Company Overview 43
5.11.1 Cepheid Pipeline Products & Ongoing Clinical Trials Overview 43
5.12 China Medical Technologies Inc (Inactive) Company Overview 44
5.12.1 China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 44
5.13 Co-Diagnostics Inc Company Overview 45
5.13.1 Co-Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 45
5.14 Corgenix Medical Corp Company Overview 46
5.14.1 Corgenix Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 46
5.15 Da An Gene Co Ltd Company Overview 47
5.15.1 Da An Gene Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.16 Diagnostics for the Real World (Europe) Ltd Company Overview 50
5.16.1 Diagnostics for the Real World (Europe) Ltd Pipeline Products & Ongoing Clinical Trials Overview 50
5.17 DiaSorin SpA Company Overview 51
5.17.1 DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 51
5.18 D-Kimia, LLC. Company Overview 54
5.18.1 D-Kimia, LLC. Pipeline Products & Ongoing Clinical Trials Overview 54
5.19 DNAE Group Holdings Ltd Company Overview 55
5.19.1 DNAE Group Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview 55
5.20 Ecoli sro Company Overview 56
5.20.1 Ecoli sro Pipeline Products & Ongoing Clinical Trials Overview 56
5.21 Ferrer inCode SL Company Overview 59
5.21.1 Ferrer inCode SL Pipeline Products & Ongoing Clinical Trials Overview 59
5.22 Fujirebio Diagnostics Inc Company Overview 60
5.22.1 Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 60
5.23 Genome Diagnostics Pvt. Ltd. Company Overview 68
5.23.1 Genome Diagnostics Pvt. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 68
5.24 HealthTell Inc Company Overview 69
5.24.1 HealthTell Inc Pipeline Products & Ongoing Clinical Trials Overview 69
5.25 Hepron Molecular Lab Inc Company Overview 71
5.25.1 Hepron Molecular Lab Inc Pipeline Products & Ongoing Clinical Trials Overview 71
5.26 Hologic Inc Company Overview 72
5.26.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 72
5.27 Imperial College London Company Overview 73
5.27.1 Imperial College London Pipeline Products & Ongoing Clinical Trials Overview 73
5.28 LifeAssay Diagnostics (Pty) Ltd Company Overview 74
5.28.1 LifeAssay Diagnostics (Pty) Ltd Pipeline Products & Ongoing Clinical Trials Overview 74
5.29 MedMira Inc Company Overview 76
5.29.1 MedMira Inc Pipeline Products & Ongoing Clinical Trials Overview 76
5.30 Medosome Biotec LLC Company Overview 77
5.30.1 Medosome Biotec LLC Pipeline Products & Ongoing Clinical Trials Overview 77
5.31 Monogram Biosciences Inc Company Overview 78
5.31.1 Monogram Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 78
5.32 NanoDiagX Company Overview 79
5.32.1 NanoDiagX Pipeline Products & Ongoing Clinical Trials Overview 79
5.33 Ortho-Clinical Diagnostics Inc Company Overview 80
5.33.1 Ortho-Clinical Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 80
5.34 Paramedical Srl Company Overview 85
5.34.1 Paramedical Srl Pipeline Products & Ongoing Clinical Trials Overview 85
5.35 ProteinLogic Ltd Company Overview 91
5.35.1 ProteinLogic Ltd Pipeline Products & Ongoing Clinical Trials Overview 91
5.36 Qiagen NV Company Overview 92
5.36.1 Qiagen NV Pipeline Products & Ongoing Clinical Trials Overview 92
5.37 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 94
5.37.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 94
5.38 Roche Diagnostics International Ltd Company Overview 95
5.38.1 Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 95
5.39 Sansure Biotech Inc Company Overview 103
5.39.1 Sansure Biotech Inc Pipeline Products & Ongoing Clinical Trials Overview 103
5.40 Seegene Inc Company Overview 106
5.40.1 Seegene Inc Pipeline Products & Ongoing Clinical Trials Overview 106
5.41 Shenzhen Mindray Bio-Medical Electronics Co Ltd Company Overview 109
5.41.1 Shenzhen Mindray Bio-Medical Electronics Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 109
5.42 Siemens Healthcare Diagnostics Inc Company Overview 111
5.42.1 Siemens Healthcare Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 111
5.43 Siemens Healthineers AG Company Overview 114
5.43.1 Siemens Healthineers AG Pipeline Products & Ongoing Clinical Trials Overview 114
5.44 Stanford University Company Overview 118
5.44.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 118
5.45 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 119
5.45.1 Syamala Srinivasa Life Sciences Pvt. Ltd Pipeline Products & Ongoing Clinical Trials Overview 119
5.46 Sysmex Corp Company Overview 121
5.46.1 Sysmex Corp Pipeline Products & Ongoing Clinical Trials Overview 121
5.47 TBG Diagnostics Ltd Company Overview 123
5.47.1 TBG Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview 123
5.48 University Medical Center Hamburg-Eppendorf Company Overview 125
5.48.1 University Medical Center Hamburg-Eppendorf Pipeline Products & Ongoing Clinical Trials Overview 125
5.49 University of British Columbia Company Overview 126
5.49.1 University of British Columbia Pipeline Products & Ongoing Clinical Trials Overview 126
5.50 University of Texas Medical Branch at Galveston Company Overview 127
5.50.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 127
5.51 University of Warwick Company Overview 128
5.51.1 University of Warwick Pipeline Products & Ongoing Clinical Trials Overview 128
5.52 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 129
5.52.1 Ustar Biotechnologies (Hangzhou) Ltd. Pipeline Products & Ongoing Clinical Trials Overview 129
5.53 Xiamen Zeesan Biotech Co.,Ltd Company Overview 130
5.53.1 Xiamen Zeesan Biotech Co.,Ltd Pipeline Products & Ongoing Clinical Trials Overview 130
6 Hepatitis Test Kits- Recent Developments 131
6.1 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 131
6.2 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin 133
6.3 Nov 06, 2019: GenMark Diagnostics reports third quarter 2019 results 133
6.4 Nov 06, 2019: OraSure announces 2019 third quarter financial results 134
6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 136
6.6 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 138
6.7 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 139
6.8 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 141
6.9 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results. 142
6.10 Oct 30, 2019: QIAGEN reports full results for third quarter and first nine months of 2019 143
7 Appendix 276
7.1 Methodology 276
7.2 About GlobalData 279
7.3 Contact Us 279
7.4 Disclaimer 279

List of Tables
Table 1: Hepatitis Test Kits - Pipeline Products by Stage of Development 17
Table 2: Hepatitis Test Kits - Pipeline Products by Segment 18
Table 3: Hepatitis Test Kits - Pipeline Products by Territory 19
Table 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path 20
Table 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 21
Table 6: Hepatitis Test Kits Companies - Pipeline Products by Stage of Development 22
Table 7: Hepatitis Test Kits - Pipeline Products by Stage of Development 24
Table 8: Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview 28
Table 9: Alinity i Assay - HCV Ag - Product Status 28
Table 10: Alinity i Assay - HCV Ag - Product Description 28
Table 11: ARCHITECT c16000 System - HbSAg Assay - Product Status 30
Table 12: ARCHITECT c16000 System - HbSAg Assay - Product Description 30
Table 13: ARCHITECT c4000 System - HbSAg Assay - Product Status 30
Table 14: ARCHITECT c4000 System - HbSAg Assay - Product Description 30
Table 15: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Status 31
Table 16: ARCHITECT c8000 System - HbSAg Next Qual Assay - Product Description 31
Table 17: Alderon Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 32
Table 18: eSystem - Qualitative HCV RNA Assay - Product Status 32
Table 19: eSystem - Qualitative HCV RNA Assay - Product Description 32
Table 20: AutoGenomics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
Table 21: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Status 33
Table 22: INFINITI High Throughput System - Hepatitis C Virus (HCV) Genotyping Test - Product Description 33
Table 23: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Status 35
Table 24: INFINITI Plus - Hepatitis C Virus (HCV) Genotyping Test - Product Description 35
Table 25: AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview 36
Table 26: Multiplexed Detection - Anti-HCV Antibodies - Product Status 36
Table 27: Multiplexed Detection - Anti-HCV Antibodies - Product Description 36
Table 28: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 37
Table 29: UniCel DxN - HCV Viral Load Test - Product Status 37
Table 30: UniCel DxN - HCV Viral Load Test - Product Description 37
Table 31: Biokit SA Pipeline Products & Ongoing Clinical Trials Overview 38
Table 32: BIO-FLASH anti-HBe Assay - Product Status 38
Table 33: BIO-FLASH anti-HBe Assay - Product Description 38
Table 34: BIO-FLASH HAV Assay - Product Status 40
Table 35: BIO-FLASH HAV Assay - Product Description 40
Table 36: BIO-FLASH HBe Ag Assay - Product Status 40
Table 37: BIO-FLASH HBe Ag Assay - Product Description 41
Table 38: Biomagnetics Diagnostics Corp Pipeline Products & Ongoing Clinical Trials Overview 42
Table 39: Diagnostic Test - Hepatitis B - Product Status 42
Table 40: Diagnostic Test - Hepatitis B - Product Description 42
Table 41: Bio-Rad Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 42: BioPlex 2200 - Hepatitis Test - Product Status 43
Table 43: BioPlex 2200 - Hepatitis Test - Product Description 43
Table 44: Boditech Med Inc Pipeline Products & Ongoing Clinical Trials Overview 45
Table 45: AFIAS-6 - Anti-HBs Test - Product Status 45
Table 46: AFIAS-6 - Anti-HBs Test - Product Description 45
Table 47: AFIAS-6 - HBsAg Test - Product Status 46
Table 48: AFIAS-6 - HBsAg Test - Product Description 46
Table 49: ichroma Test - Anti-HBs - Product Status 46
Table 50: ichroma Test - Anti-HBs - Product Description 46
Table 51: ichroma Test - HBsAg - Product Status 47
Table 52: ichroma Test - HBsAg - Product Description 47
Table 53: ichroma Test - HCV - Product Status 47
Table 54: ichroma Test - HCV - Product Description 47
Table 55: CeMines, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 49
Table 56: Diagnostic Test - Hepatitis C - Product Status 49
Table 57: Diagnostic Test - Hepatitis C - Product Description 49
Table 58: Cepheid Pipeline Products & Ongoing Clinical Trials Overview 50
Table 59: Xpert HCV Quant Assay - Product Status 50
Table 60: Xpert HCV Quant Assay - Product Description 50
Table 61: China Medical Technologies Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51
Table 62: Diagnostic Assay - HCVA - Product Status 51

List of Figures
Figure 1: Hepatitis Test Kits - Pipeline Products by Stage of Development 15
Figure 2: Hepatitis Test Kits - Pipeline Products by Segment 16
Figure 3: Hepatitis Test Kits - Pipeline Products by Territory 17
Figure 4: Hepatitis Test Kits - Pipeline Products by Regulatory Path 18
Figure 5: Hepatitis Test Kits - Pipeline Products by Estimated Approval Date 19

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[肝炎検査キット:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆